Cite

HARVARD Citation

    Gaballa, M. et al. (2022). Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leukemia & lymphoma. 63 (3), pp. 710-721. [Online]. 
  
Back to record